- AstraZeneca has sold its 7.7% stake in Moderna for more than $1 billion, The Times reported.
- The sale came after Modern'a shares soared on the back of its coronavirus vaccine breakthrough.
- AstraZeneca is retaining a partnership with Moderna on other disease treatments.
The report added that it was not clear over what period British-based AstraZeneca sold its holding in Moderna.
AstraZeneca and Moderna did not immediately respond to requests for comment.
AstraZeneca is retaining a partnership with Moderna on other disease treatments and could sell its AstraZeneca/Oxford University Covid-19 vaccine on a commercial basis in the future if the virus becomes endemic, the report added.
Moderna, whose vaccine is cleared for emergency use against Covid-19 in the United States, said last week it was expecting sales of $18.4 billion from its coronavirus vaccine this year.